Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

Dexamethasone suppressible hyperaldosteronism: insights into adrenal physiology.

Connell JM, Jardine A, Fraser R.

Adv Nephrol Necker Hosp. 1990;19:69-77. No abstract available.

PMID:
2154082
[PubMed - indexed for MEDLINE]
2.

[Primary dexamethasone-suppressible hyperaldosteronism and hyperprolactinemia].

Veglio F, Pinna G, Rabbia F, Mulatero P, Chiandussi L.

Minerva Endocrinol. 1992 Jan-Mar;17(1):43-6. Italian.

PMID:
1323053
[PubMed - indexed for MEDLINE]
3.

Dexamethasone-suppressible hyperaldosteronism. Adrenal transition cell hyperplasia?

Connell JM, Kenyon CJ, Corrie JE, Fraser R, Watt R, Lever AF.

Hypertension. 1986 Aug;8(8):669-76.

PMID:
3015796
[PubMed - indexed for MEDLINE]
Free Article
4.

Dexamethasone-suppressible hyperaldosteronism.

New MI, Siegal EJ, Peterson RE.

J Clin Endocrinol Metab. 1973 Jul;37(1):93-100. No abstract available.

PMID:
4351777
[PubMed - indexed for MEDLINE]
5.

Hypertension corrected and aldosterone responsiveness to renin-angiotensin restored by long-term dexamethasone in glucocorticoid-suppressible hyperaldosteronism.

Woodland E, Tunny TJ, Hamlet SM, Gordon RD.

Clin Exp Pharmacol Physiol. 1985 May-Jun;12(3):245-8.

PMID:
2992855
[PubMed - indexed for MEDLINE]
6.

Anomalous postural aldosterone response in glucocorticoid-suppressible hyperaldosteronism.

Ganguly A, Grim CE, Weinberger MH.

N Engl J Med. 1981 Oct 22;305(17):991-3. No abstract available.

PMID:
6268979
[PubMed - indexed for MEDLINE]
7.

Aldosterone production after suppression of corticotropic secretory activity.

Spark RF, Gordon SJ, Dale SL, Melby JC.

Arch Intern Med. 1968 Nov;122(5):394-8. No abstract available.

PMID:
4301259
[PubMed - indexed for MEDLINE]
8.

Familial, dexamethasone-suppressible, normokalemic hyperaldosteronism.

Grim CE, Weinberger MH.

Pediatrics. 1980 Mar;65(3):597-604.

PMID:
6987607
[PubMed - indexed for MEDLINE]
9.

Dexamethasone-suppressible hyperaldosteronism: a large new kindred.

O'Mahony S, Burns A, Murnaghan DJ.

J Hum Hypertens. 1989 Aug;3(4):255-8.

PMID:
2552113
[PubMed - indexed for MEDLINE]
10.

ACTH effects on aldosterone, cortisol, and other steroids.

Biglieri EG.

Hosp Pract (Off Ed). 1989 Jan 15;24(1):145-9, 152, 157-9 passim. No abstract available.

PMID:
2536040
[PubMed - indexed for MEDLINE]
11.

Dexamethasone suppressible hyperaldosteronism in a child with nephrosclerosis.

Lee SM, Lightner E, Witte M, Oberfield S, Levine L, New MI.

Acta Endocrinol (Copenh). 1982 Feb;99(2):251-5.

PMID:
6277130
[PubMed - indexed for MEDLINE]
12.

Episodic secretion of aldosterone in primary aldosteronism: relationship to cortisol.

Vetter H, Berger M, Armbruster H, Siegenthaler W, Werning C, Vetter W.

Clin Endocrinol (Oxf). 1974 Jan;3(1):41-8. No abstract available.

PMID:
4366076
[PubMed - indexed for MEDLINE]
13.

A new family with dexamethasone-suppressible hyperaldosteronism: aldosterone unresponsiveness to angiotensin II.

Fallo F, Sonino N, Armanini D, Luzzi T, Pedini F, Pasini C, Mantero F.

Clin Endocrinol (Oxf). 1985 Jun;22(6):777-85.

PMID:
2990765
[PubMed - indexed for MEDLINE]
14.

Study on clinical and endocrine characteristics of dexamethasone-suppressible hyperaldosteronism compared with those in primary aldosteronism owing to aldosterone-producing adenoma.

Yamakita N, Yasuda K, Noritake N, Mercado-Asis LB, Murase H, Mune T, Morita H, Miura K.

Acta Endocrinol (Copenh). 1989 Sep;121(3):334-44.

PMID:
2552725
[PubMed - indexed for MEDLINE]
15.

A case of glucocorticoid-responsive hyperaldosteronism.

Miura K, Yoshinaga K, Goto K, Katsushima I, Maebashi M, Demura H, Iino M, Demura R, Torikai T.

J Clin Endocrinol Metab. 1968 Dec;28(12):1807-15. No abstract available.

PMID:
4301765
[PubMed - indexed for MEDLINE]
16.

Manipulation by corticotropin and cortisol of aldosterone secretion in primary aldosteronism.

Newton MA, Laragh JH.

Arch Intern Med. 1969 Feb;123(2):147-51. No abstract available.

PMID:
4303267
[PubMed - indexed for MEDLINE]
17.

Hypertension of childhood with suppressed renin.

New MI, Levine LS.

Endocr Rev. 1980 Fall;1(4):421-30. Review. No abstract available.

PMID:
6265200
[PubMed - indexed for MEDLINE]
18.

Dexamethasone-suppressible hyperaldosteronism: pathophysiology, clinical aspects, and new insights into the pathogenesis.

Fallo F, Sonino N, Boscaro M, Armanini D, Mantero F, Dörr HG, Knorr D, Kuhnle U.

Klin Wochenschr. 1987 May 15;65(10):437-44.

PMID:
3037179
[PubMed - indexed for MEDLINE]
19.

Glucocorticoid-suppressible hyperaldosteronism: from confusion to conclusion?

Jamieson A, Connell JM, Fraser R.

J Mol Endocrinol. 1993 Feb;10(1):3-5. Review. No abstract available.

PMID:
8383977
[PubMed - indexed for MEDLINE]
20.

Effects of naloxone on the pituitary-adrenal axis in patients with dexamethasone-suppressible hyperaldosteronism.

Fallo F, Boscaro M, Sonino N, Mantero F.

Clin Endocrinol (Oxf). 1987 Feb;26(2):163-8.

PMID:
2822294
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk